Skip to main content
Barinthus Biotherapeutics plc. logo

Barinthus Biotherapeutics plc. — Investor Relations & Filings

Ticker · BRNS ISIN · US91864C1071 LEI · 213800KQ9EAOKPWN8A33 US Manufacturing
Filings indexed 239 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country GB United Kingdom
Listing US BRNS

About Barinthus Biotherapeutics plc.

https://www.barinthusbio.com/

Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company that develops novel immunotherapies designed to guide T cells to control disease. The company is advancing a new generation of antigen-specific immunotherapeutics for treating autoimmunity, chronic infectious diseases, and cancer. Its therapeutic approach focuses on creating candidates that can overcome these conditions by modulating the body's T cell response. The development pipeline includes programs targeting various indications, with a strategic focus on immunology and inflammatory diseases.

Recent filings

Filing Released Lang Actions
10-Q - Barinthus Biotherapeutics plc. (0001828185) (Filer)
Interim / Quarterly Report
2026-04-30 English
8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
Regulatory Filings
2026-04-30 English
8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
Regulatory Filings
2026-04-22 English
8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
Regulatory Filings
2026-02-23 English
8-K
Regulatory Filings
2026-01-06 English
8-K
Regulatory Filings
2025-12-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.